Form 4/A for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp

Accepted 2022-02-04 00:00:00 ET · period of report 2021-06-23 · accession 0001709738-22-000001 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MA	2022-02-04	2021-06-23+	NMTC	Christianson Mark	Business Development Dir	S - Sale	$6.72	-11.9K	351.2K	-3%	-$79.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-06-23	S	D	11,300	$6.74	351,769	D	—	—	(F1) The price reported in Column 4 is a weighted average price. These shares of the issuer's common stock were sold in multiple transactions at prices ranging from $6.50 to $6.97, inclusive. The reporting person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. (F2) This amendment is being filed to correct the number of shares beneficially owned by the reporting person following the reported transaction. The issuer effected a one-for-three reverse stock split of shares of its common stock on March 31, 2021, and the total number of shares held by the reporting person has been corrected to adjust for the split.
2	Common	Common Stock	2021-06-24	S	D	600	$6.30	351,169	D	—	—	(F2) This amendment is being filed to correct the number of shares beneficially owned by the reporting person following the reported transaction. The issuer effected a one-for-three reverse stock split of shares of its common stock on March 31, 2021, and the total number of shares held by the reporting person has been corrected to adjust for the split.